Literature DB >> 22285446

How easily can omission of patients, or selection amongst poorly-reproducible measurements, create artificial correlations? Methods for detection and implications for observational research design in cardiology.

Darrel P Francis1.   

Abstract

BACKGROUND: When reported correlation coefficients seem too high to be true, does investigative verification of source data provide suitable reassurance? This study tests how easily omission of patients or selection amongst irreproducible measurements generate fictitious strong correlations, without data fabrication. METHOD AND
RESULTS: Two forms of manipulation are applied to a pair of normally-distributed, uncorrelated variables: first, exclusion of patients least favourable to a hypothesised association and, second, making multiple poorly-reproducible measurements per patient and choosing the most supportive. Excluding patients raises correlations powerfully, from 0.0 ± 0.11 (no patients omitted) to 0.40 ± 0.11 (one-fifth omitted), 0.59 ± 0.08 (one-third omitted) and 0.78 ± 0.05 (half omitted). Study size offers no protection: omitting just one-fifth of 75 patients (i.e. publishing 60) makes 92% of correlations statistically significant. Worse, simply selecting the most favourable amongst several measurements raises correlations from 0.0 ± 0.12 (single measurement of each variable) to 0.73 ± 0.06 (best of 2), and 0.90 ± 0.03 (best of 4). 100% of correlation coefficients become statistically significant. Scatterplots may reveal a telltale "shave sign" or "bite sign". Simple statistical tests are presented for these suspicious signatures in single or multiple studies.
CONCLUSION: Correlations are vulnerable to data manipulation. Cardiology is especially vulnerable to patient deletion (because cardiologists ourselves might completely control enrolment and measurement), and selection of "best" measurements (because alternative heartbeats are numerous, and some modalities poorly reproducible). Source data verification cannot detect these but tests might highlight suspicious data and--aggregating across studies--unreliable laboratories or research fields. Cardiological correlation research needs adequately-informed planning and guarantees of integrity, with teeth.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22285446     DOI: 10.1016/j.ijcard.2011.12.018

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Method for percutaneously introducing, and removing, anatomical stenosis of predetermined severity in vivo: the "stenotic stent".

Authors:  Nicolas Foin; Sayan Sen; Ricardo Petraco; Sukhjinder Nijjer; Ryo Torii; Chrysa Kousera; Christopher Broyd; Vikram Mehta; Yun Xu; Jamil Mayet; Alun Hughes; Carlo Di Mario; Rob Krams; Darrel Francis; Justin Davies
Journal:  J Cardiovasc Transl Res       Date:  2013-06-04       Impact factor: 4.132

2.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

3.  Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.

Authors:  Andreas Kyriacou; Punam A Pabari; Jamil Mayet; Nicholas S Peters; D Wyn Davies; P Boon Lim; David Lefroy; Alun D Hughes; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  Int J Cardiol       Date:  2013-10-16       Impact factor: 4.164

Review 4.  Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.

Authors:  Alexandra N Nowbar; Michael Mielewczik; Maria Karavassilis; Hakim-Moulay Dehbi; Matthew J Shun-Shin; Siana Jones; James P Howard; Graham D Cole; Darrel P Francis
Journal:  BMJ       Date:  2014-04-28

Review 5.  Evidence-based recommendations for PISA measurements in mitral regurgitation: systematic review, clinical and in-vitro study.

Authors:  Michela Moraldo; Fabrizio Cecaro; Matthew Shun-Shin; Punam A Pabari; Justin E Davies; Xiao Y Xu; Alun D Hughes; Charlotte Manisty; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-12-11       Impact factor: 4.164

6.  Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.

Authors:  Zachary I Whinnett; Darrel P Francis; Arnaud Denis; Keith Willson; Patrizio Pascale; Irene van Geldorp; Maxime De Guillebon; Sylvain Ploux; Kenneth Ellenbogen; Michel Haïssaguerre; Philippe Ritter; Pierre Bordachar
Journal:  Int J Cardiol       Date:  2013-03-05       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.